Landis G. Michael
SEC insider (Form 3/4/5 filer). CIK 0001548560. Chief Financial Officer at Polaryx Therapeutics, Inc. (PLYX). 1 reported Form 4/5 transaction since Sep 2024; latest on Feb 18, 2026. Located in PARAMUS, NJ.
Companies Landis G. Michael has filed insider reports for
- Polaryx Therapeutics, Inc. (PLYX): Director, Officer, Chief Financial Officer
Landis G. Michael
CIK: 0001548560
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PLYX
Polaryx Therapeutics, Inc.
DirectorOfficer